Bellevue Healthcare (LON:BBH) Shares Up 0.2% - Time to Buy?

Key Points

• Bellevue Healthcare's stock rose 0.2% during Tuesday's mid-day trading, with a last traded price of GBX 113.81 ($1.51).
• The company has a market cap of £280.49 million and a PE ratio of -17.31, indicating potential challenges in profitability.
• Bellevue Healthcare Trust plc targets a total dividend of 3.5 pence per share for the first financial period, primarily funded from capital.

Bellevue Healthcare (LON:BBH - Get Free Report)'s stock price traded up 0.2% during trading on Tuesday . The stock traded as high as GBX 115 ($1.55) and last traded at GBX 113.81 ($1.53). 2,334,997 shares were traded during trading, an increase of 6% from the average session volume of 2,195,712 shares. The stock had previously closed at GBX 113.60 ($1.53).

Bellevue Healthcare Price Performance

The stock has a market cap of £277.51 million and a P/E ratio of -17.13. The company has a fifty day moving average of GBX 118.14 and a 200 day moving average of GBX 124.48.

Bellevue Healthcare (LON:BBH - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported GBX 0.19 ($0.00) EPS for the quarter. Bellevue Healthcare had a negative return on equity of 4.48% and a net margin of 169.10%.

Bellevue Healthcare Company Profile

Bellevue Healthcare Trust plc is a high conviction, long-only investment trust invested in listed or quoted global healthcare equities. It is unconstrained and able to invest regardless of market cap, sub sector or region, and the portfolio is concentrated with a maximum of 35 holdings. The target total dividend in the first financial period is 3.5 pence per ordinary share (to be paid mostly out of capital) and in subsequent financial years will be set at 3.5 per cent.